to know about lic ulip (unit linked plans),lic ulip plans,lic ulip nav,lic ulip best plans,lic ulip market plus,lic ulip rate,lic ulip market plus nav,lic ulip policy status,lic ulip surrender form,lic ulip returns,lic ulip profit plus,lic ulip premium online,lic ulip performance,lic ulip plan 180,lic ulip pension plus,lic ulip products,lic ulip price,lic ulip rates,lic ulip pay premium online,lic ulip bhima plus policy,net asset value of lic ulip plans and more details
The Director General of Civil Aviation (DGCA) suspended the Scheduled Operator Permit of Kingfisher Airlines till further orders. It can’t resume operations until the DGCA is satisfied and they should have concrete plans regarding safety of operations
Fore more News please visit www.timesofindia.com
Upon expiry of the validity of the certificate possessed by an associated person, the certificate may get revalidated, provided the associated person successfully completes a programme of continuing professional education, as specified by NISM during 12 months preceding the date of expiry of the certificate, or by passing the relevant NISM Certification Examination before the expiry of the existing certificate. A candidate with a valid NISM/ AMFI certificate is required to complete the mandated 2 day NISM CPE Programme within a period of 12 months preceding the date of the expiry of the said certificate. As per the revised CPE requirements, CPE Programme can be successfully completed by a candidate by either attending the relevant CPE Programme on 2 consecutive days or with a gap. However, both the days of CPE Programme must be completed during 12 months preceding the date of expiry of the certificate. Attending only 1 day of the relevant CPE Programme during 12 months preceding the date of expiry of the certificate shall not be considered as successful completion. The certificate will be revalidated for a period of 3 years from the date of expiry of the existing certificate. The CPE Programme for Mutual Fund Distributors as per the revised requirements will be available from June 1, 2012.
To know more details please visit www.nism.ac.in
Pharmaceutical companies in India are not the Indian companies but also the MNCs that are becoming the part of the race. Indian pharmaceutical market in 2008 was $7,743m and if compared to year 2007 it was 4% more than that. It is expected that Indian pharmaceutical market will grow more than the global pharmaceutical market and will become $15,490 million in 2014. Today Indian pharmaceutical industry is the second most fastest growing industry displaying the revenue of Rs 25,196.48 crore and growth of 27.32 percent. Top pharmaceutical companies in India are also acquiring the small companies worldwide to further expand the market. Pharmaceutical drugs injections, tablets, capsules; syrups are the products of pharma companies in India along with many more.